|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0034656,
umls-concept:C0045093,
umls-concept:C0205195,
umls-concept:C0282461,
umls-concept:C0332283,
umls-concept:C0332293,
umls-concept:C0338265,
umls-concept:C0441772,
umls-concept:C0684249,
umls-concept:C0750729,
umls-concept:C1516213,
umls-concept:C1524062
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-5-9
|
|
pubmed:abstractText |
This randomised phase III study investigated if in responsive and stable disease (SD) stage IV patients after two courses of cisplatin and gemcitabine, single-agent gemcitabine (experimental arm) was not inferior in terms of overall survival (OS) to cisplatin-gemcitabine (standard arm).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BarberaSS,
pubmed-author:BaroniGG,
pubmed-author:BruzziPP,
pubmed-author:BuosiRR,
pubmed-author:CrinòLL,
pubmed-author:DongiovanniVV,
pubmed-author:FiorettiMM,
pubmed-author:GarettoLL,
pubmed-author:MasottiAA,
pubmed-author:MazzantiPP,
pubmed-author:MichettiGG,
pubmed-author:NovelloSS,
pubmed-author:ScagliottiG VGV,
pubmed-author:SelvaggiGG,
pubmed-author:SpataforaMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
903-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17351253-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17351253-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17351253-Cisplatin,
pubmed-meshheading:17351253-Deoxycytidine,
pubmed-meshheading:17351253-Drug Administration Schedule,
pubmed-meshheading:17351253-Female,
pubmed-meshheading:17351253-Follow-Up Studies,
pubmed-meshheading:17351253-Humans,
pubmed-meshheading:17351253-Lung Neoplasms,
pubmed-meshheading:17351253-Male,
pubmed-meshheading:17351253-Middle Aged,
pubmed-meshheading:17351253-Neoplasm Staging,
pubmed-meshheading:17351253-Survival Analysis,
pubmed-meshheading:17351253-Time Factors,
pubmed-meshheading:17351253-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone.
|
|
pubmed:affiliation |
Department of Clinical and Biological Sciences, Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy. silvia.novello@unito.it
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
